Keyphrases
Vaccine Platform
100%
Malaria Antigens
100%
VAR2CSA
100%
Particle-based
100%
Placental Malaria
100%
Virus-like
100%
Monovalent Cations
45%
Streptavidin
45%
Soluble Protein
27%
Immunization
27%
Vaccine Antigen
27%
Chondroitin Sulfate
18%
Plasmodium Falciparum
18%
Biotin
18%
Clinical Testing
18%
Vaccine Response
18%
High Efficacy
9%
Causes of Mortality
9%
Coat Protein
9%
Particle Assembly
9%
Infected Erythrocytes
9%
Human Papillomavirus Vaccine
9%
Display Platform
9%
Immune Response
9%
Chimeric VLPs
9%
Fused Protein
9%
Human Receptor
9%
Malaria in Pregnancy
9%
Protective Immune Response
9%
Acceptor Site
9%
Biotinylation
9%
Severe Morbidity
9%
C57BL
9%
Placenta
9%
HPV16
9%
Antibody Titer
9%
Titre
9%
Sequestration
9%
Immunology and Microbiology
Virus-Like Particle
100%
Immune Response
22%
Plasmodium falciparum
22%
Virus Like Particle Vaccine
22%
Antibody Titer
11%
Human Papillomavirus Type 16
11%
Biotinylation
11%
Placenta
11%
Erythrocyte
11%
C57BL 6 Mouse
11%
Cervarix
11%
Binding Site
11%
Pharmacology, Toxicology and Pharmaceutical Science
Virus Like Agent
100%
Protein-Based Vaccine
33%
Virus Like Particle Vaccine
22%
Coat Protein
11%